# BrightSpring Health Services Inc. (BTSG) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $60.73, market value $12.0 billion.

## Valuation
- **P/E (trailing): 54.2×** (5-yr avg 43.0×, 3-yr avg 43.0×). BrightSpring Health Services Inc. trades at 54.2× trailing earnings, well above its own five-year average of 43.0×: investors are paying up relative to the company's past. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 26.7×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.02**. A PEG of 0.02 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.8×**. Each dollar of revenue is priced at 0.8×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 6.1×**. The shares trade at 6.1× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 23.7×**. Enterprise value is 23.7× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 3.3%** (5-yr avg 1.5%). Free cash flow equals 3.3% of the market value, above its five-year average of 1.5%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 1.8%**. The inverse of the P/E: 1.8% of the price is earned each year.

## Profitability
- **Gross margin: 12.4%**. BrightSpring Health Services Inc. keeps 12.4% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 3.1%**. 3.1% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 1.5%**. 1.5% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.2%**. 10.2% on shareholders' equity is solid.
- **Return on invested capital: 8.2%**. Return on all capital, debt included, is 8.2%.
- **Return on assets: 5.7%**. Each dollar of assets produces 5.7% of profit.

## Growth
- **Revenue growth (1 yr): 28.2%** (3-yr 18.7%/yr). Revenue grew 28.2% over the last year.
- **EPS growth (1 yr): 1066.7%**. Earnings per share rose 1066.7%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 1.34**. Debt is 1.34 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 4.0×**. It would take 4.0 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Altman Z-score: 4.17**. A Z-score of 4.17 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. BrightSpring Health Services Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (16 analysts). 16 analysts cover BrightSpring Health Services Inc.; the consensus is strong_buy, with an average price target of $78.50 (+29% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 152.1%** (YTD 62.2%, 3-mo 5.8%). The shares are up 152.1% over twelve months including dividends.
- **From 52-week high: -17.7%** (142.3% above the low). Trading 18% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 48**. An RSI of 48 is neutral.
- **Beta (1 yr): 1.37** (volatility 45%). Beta of 1.37 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BTSG · Page: https://foliofundamentals.com/stocks/btsg

Not investment advice.